PL-2.2 Diabetes: The new injectables - Glp1 agonists and new insulins when and how to use
Monday November 27, 2017 from 13:30 to 14:00

Tina Kader, Canada

Assistant Professor

Department of Medicine

McGill University


Treatment of diabetes is a rapidly changing world with newer classes and molecules arriving yearly; This 20 minute presentation will focus on Glp1 class and newer insulins; In the glp1 class discussion will focus on currently available agents; case based presentation to emphasize when and how to use . Newer Glp1 agents are coming to the market soon and these will be discussed.  Newer insulins are available and the disucssion will be around newer basals such as toujeo and tresiba emphasizing the benefits of these longer insulins and he newest rapid analog Fiasp will be mentioned.






As a result of attending this session, participants will be able to:

  • Understand the currently available glp1 agonists and new ones that are coming
  • Understand the ideal patient for these agents potential benefits and side effects
  • Be aware of the newest basal insulins ;
  • Understand which agents to use these  ultralong acting insulins 5)be aware of the latest rapid analog


Recommended Reading Uploads

Lectures by Tina Kader

When Session Talk Title Room
13:00 - 14:35
Plenary - 2 Diabetes: The new injectables - Glp1 agonists and new insulins when and how to use Westmount/Outremont
14:40 - 15:40
Workshops - B Diabetes: Bring your problem cases Pointe-aux-Trembles
16:00 - 17:00
Workshops - C New monitoring devices to improve diabetes care Fundy

© 2018 2017 McGill Family Physician Refresher Course